Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 17, 2010
Mixed paratesticular liposarcoma with osteosarcoma elementsLisardo Ugidos, Ana Suárez, Antonio Cubillo, et al.
Oncology|March 30, 2021
A Predictive Score of Antitumour Activity of Novel Agents in Cancer Patients Treated in Early Phase StudiesRunhan Liu, Ana Gomes, Geriletu Ao, et al.
Investigational New Drugs|July 21, 2021
Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studiesGeriletu Ao, Maria de Miguel, Ana Gomes, et al.
Investigational New Drugs|October 17, 2008
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patientsLisardo Ugidos, Salvadora Delgado, Carlos Conill, et al.
Case Reports in Oncology|August 15, 2024
Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case ReportMarisa Torres Velasco, Rafael Álvarez Gallego, Paloma Peinado, et al.
American Journal of Clinical Oncology|September 10, 2025
A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOXRafael Álvarez-Gallego, Teresa Macarulla, Berta Laquente, et al.
American Journal of Clinical Oncology|July 6, 2018
Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal CancerAntonio Cubillo, Rafael Álvarez-Gallego, Manuel Muñoz, et al.
Cancers|July 29, 2023
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and NeckAnagha Gogate, Bryan Bennett, Zia Poonja, et al.
American Journal of Clinical Oncology|November 29, 2024
Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait ProgramCésar Muñoz, María-C Riesco Martinez, Lisardo Ugidos, et al.
Pageof 1